Whether you're growing from $200,000 to $1 million or hoping to take $20,000 to $100,000 over a period of 10 years, you'll need an average 17.5% annual return.

While this would amount to market-beating returns, all three companies below have market capitalizations below $7 billion and are still in the early chapters of their long-term growth stories.

Growing revenue between 27% and 57% over the last 12 months, Doximity (NYSE: DOCS), Medpace (NASDAQ: MEDP), and Progyny (NASDAQ: PGNY) look poised to meet this 17.5% annual return threshold. This is especially true considering that each company has carved out a unique niche in healthcare verticals that should only grow over the long haul.

Continue reading

Source Fool.com